Absorbable Nasal Implant Devices Market By Product Type (Drug Eluting Absorbable Nasal Implant Devices, Non-Drug Eluting Nasal Implants Devices), By Material Type (Polymer, Carboxy Methyl Cellulose (CMC), Others), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers), and Geography.  

Absorbable Nasal Implant Devices Market size was valued at USD 578 million in 2022 and is poised to grow at a significant CAGR of 6.8% from 2023-2029. Absorbable Nasal implant is a device that supports the nasal cartilage while enhancing breathing for people suffering from nasal blockage. The implants help to treat nasal obstructions or collapse of the nasal valve, also known as vestibular stenosis, caused by a number of reasons, including larger turbinates, septal deviation, and weak upper and lower lateral cartilage of the nasal wall. According to CDC, in U.S. about 28.9 million adults suffer from sinusitis making up about 11.6% of the adult population. The prevalence of medical conditions of chronic sinusitis, polyps, and nonallergic rhinitis and the shifting preference of people for nose reshaping or rhinoplasty is currently driving the absorbable nasal implants market. The increasing number of patients suffering from nasal valve collapse including stuffiness, and inability to breathe through one or both nostrils also boost the market. Over 80% of the overall airway resistance is caused by the nasal valve collapsing. Around 1 million treatments are performed to relieve the symptoms of nasal blockage, and over 3 million Americans contact a doctor about it, further increasing the market value. Based on the material, the polymer segment holds the largest market owing to the increased use of polymer material in the manufacturing of absorbable nasal implants. For instance, the LATERA nasal implants are prepared from PLLA (poly-L-lactide) polymer, which is absorbed by the nasal tissues. Moreover, the development of biodegradable nasal implants, nasal dressing, and further development of technology has opened up several opportunities for the development of the market. But the growing number of health and procedural risks associated with nasal surgery like nosebleeds, bursting of small blood vessels under the skin, and nerve damage may hinder the adoption of absorbable nasal implants hindering the growth of the market. However, the increasing demand for nasal implants for medical and aesthetic conditions, rising medical emergency nasal surgery, and growing demand for cosmetic surgeries have positively impacted the absorbable nasal implants market and are expected to expand in the forecasted period.

Absorbable Nasal Implant Devices Market Key Developments:

• In May 2022, Medtronic acquired Intersect ENT's PROPEL™ and SINUVA™ (mometasone furoate) sinus implant product lines and technology, intellectual property, and Menlo Park, Calif., facility.
• In February 2019, Spirox launched its Latera Absorbable Nasal Implant which is indicated & designed to treat nasal obstruction due to nasal valve collapse associated with nasal congestion or allergic rhinitis.